Title: Faculty & research interests





David G Savage, MD
Professor of Clinical Medicine;
Associate Member

Department: Medicine

IP 10

Personal Website

Disease Models: Hematological Diseases

Stem Cell Categories: Adult stem cells

Model Organisms:

Themes: Blood

Dr. savage is the acting chief of the adult hematopoietic stem cell transplant program, in which their practice is limited to high dose chemotherapy and autologous stem cell transplantation for myeloma and lymphoma;


Halter J, Schüpbach WM, Casali C, Elhasid R, Fay K, Hammans S, Illa I, Kappeler L, Krähenbühl S, Lehmann T, Mandel H, Marti R, Mattle H, Orchard K, Savage D, Sue CM, Valcarcel D, Gratwohl A, Hirano M.
Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach. Bone Marrow Transplantation :. (2010)

Montanari F, O'Connor OA, Savage DG, Zain JM, Venkatraman S, McCormick EK, Crook MT, Tsao L , Sevilla DW, Bhagat G, Alobeid B.
Bone marrow involvement in patients with post-transplant lymphoproliferative disorders: incidence and prognostic factors. Human Pathology . :. (2010)

Manga K, Serban G, Schwartz J, Slotky R, Patel N, Fan J, Bai X, Chari A, Savage D, Suciu-Foca N, Colovai AI.
Increased adenosine triphosphate production by peripheral blood CD4(+) cells in patients with hematologic malignancies treated with stem cell mobilization agents. Human Immunology 71:652-58. (2010)

Phillips AA, Shapira I, Willim RD, Sanmugaraiah J, Solomon WBC, Horwitz SM, Savage DG, Bhagat G, Soff G, Zain JM, Alobeid B, Seshan VE, O’Connor OA.
A critical analysis of prognostic factors in North American patients with human T-cell lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma: a multicenter clinicopathologic experience and new prognostic score. Cancer 116:3438-46. (2010)

Phillips AA, Willim RD, Savage DG, Horwitz SM, O’Connor OA.
A multi-institutional experience of autologous stem cell transplantation in North American patients with human T-cell lymphotropic virus type-1 adult T-cell leukemia/lymphoma suggests ineffective salvage of relapsed patients. Leukemia & Lymphoma 15:1-4. (2009)

bottom rounded